@pepswithjess posted a TikTok with 161.9K views directing followers to use code "MARJI" for Peptira products. The video itself doesn't make specific medical claims, but it's promoting access to peptide therapies without providing scientific context or safety information.
What does this video actually claim?
The video is essentially a promotional post for Peptira peptides using a discount code. Coach Jesse responds to requests for "source" by providing the company name and discount code rather than scientific sources.
This type of content is common in the peptide influencer space. Creators often share affiliate codes while avoiding explicit medical claims that could trigger platform restrictions. The problem is followers assume these endorsements come with scientific backing.
What's the issue with peptide promotion on social media?
Most peptides promoted online exist in a regulatory gray area. The FDA hasn't approved peptides like BPC-157, TB-500, or GHK-Cu for human use outside of research settings.
A 2023 FDA warning letter to multiple peptide companies specifically called out marketing of non-approved peptides as dietary supplements. The agency stated these products are "new drugs" requiring FDA approval before marketing.
When influencers promote these products without mentioning regulatory status or potential risks, they're leaving followers uninformed about what they're actually buying.
What does the research actually show?
The peptide evidence is mostly preliminary. BPC-157 has shown healing effects in rat studies, but human clinical trials are limited. A 2022 review in Biomedicines found promising animal data but noted the lack of human safety studies.
TB-500 research is even thinner. Most studies focus on the parent protein thymosin beta-4 rather than the synthetic fragment TB-500 sold commercially.
GHK-Cu has more human data for skin applications, with studies showing improved wound healing and collagen synthesis. But systemic use data is sparse.
What should you know before buying peptides?
Quality control is a major concern. A 2021 analysis published in JAMA found that 58% of compounded peptide products contained incorrect concentrations compared to labeling.
Many peptide companies operate as "research chemical" suppliers to avoid FDA oversight. Products may not meet pharmaceutical manufacturing standards.
If you're considering peptides, work with a licensed healthcare provider who can assess your individual situation and source pharmaceutical-grade products where available. Don't rely on social media discount codes as your research source.